Connext
Biotechnology Research · 11 Employees
Email Address: info@connext.co.kr
- Overview
- Employees
Access 2 Verified Employees Profiles for ConnextUnlock Free Contacts Now
About
Connext is clinical stage biotech company located in South Korea. We are developing CNT201, recombinant collagenase for Dupuytren's contracture (orthopedic) and Peyronie's disease (urology) and CNT101, most optimized TLR5 agonist-based immune modulator for immune disorder such as acute GVHD. IND for Phase 1/2 Dupuytren's contracture study was cleared by the US FDA in June 2023 and IND for acute GVHD was approved by MFDS in Korea in January 2023.
Website
Year Founded
2017
Social Media
LinkedinFacebook
Industry
Biotechnology Research
HQ Location
59, Yangho-gil
Yeongcheon-si, Gyeongsangbuk-do 38822, KR
Keywords
collagenaseTLR5 agonistorthopedicurologyPeyronie's diseaseDupuytren's contractureCelluliteAestheticSpecialtyand Niche
Location
- 59, Yangho-gil Yeongcheon-si, Gyeongsangbuk-do 38822, KR
Email Formats
Sign up for free credits and discover verified email addresses of Connext
FormatExamples
first + last
andywarhol@co.kr
first_initial + last
awarhol@co.kr
first + last_initial
andyw@co.kr
first
andy@co.kr
last
warhol@co.kr
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Connext and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.